THE POLYOMAVIRUS MIDDLE T-ANTIGEN ONCOGENE ACTIVATES THE HIPPO-PATHWAY TUMOR SUPPRESSOR LATS KINASE IN A SRC-DEPENDENT MANNER.

Matan Shanzer Nina Reuven Rom Keshet Yosef Shaul
Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot

The polyomavirus middle T antigen (PyMT) is an oncogene which activates the non-receptor tyrosine kinase, c-Src, and physically interacts with Taz. Taz is a pro-oncogenic transcription co-activator of the Tead transcription factors. The Hippo tumor suppressor pathway activates the Lats kinase, which phosphorylates Taz, leading to its nuclear exclusion and functionally neutralizing it in supporting Tead co-activation.  We found that Taz was required for transformation by PyMT, but counter intuitively, Taz was exclusively cytoplasmic in the presence of PyMT. We demonstrate that PyMT induced Taz phosphorylation by Lats in a Src-dependent manner. Furthermore, Taz mutants that escaped Lats phosphorylation were refractory to PyMT-induced cytoplasmic retention. Yap, the Taz paralog, was similarly regulated by PyMT.  Our study demonstrates activation of the Hippo tumor suppressor pathway by a viral oncogene.  Furthermore, it reveals a non-canonical, Tead-independent role for Taz in transformation.        








 




Powered by Eventact EMS